Cargando…
Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of etanercept in patients with moderately active rheumatoid arthritis despite DMARD therapy
This study evaluated the efficacy and safety of adding etanercept to disease-modifying antirheumatic drugs (DMARDs) in patients with moderately active rheumatoid arthritis (RA). This randomized, double-blind, placebo-controlled study (ClinicalTrials.gov #NCT01313208) enrolled RA patients with Diseas...
Autores principales: | Hobbs, Kathryn, Deodhar, Atul, Wang, Brian, Bitman, Bojena, Nussbaum, Joyce, Chung, James, Collier, David H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359699/ https://www.ncbi.nlm.nih.gov/pubmed/25793152 http://dx.doi.org/10.1186/s40064-015-0895-9 |
Ejemplares similares
-
The effect of etanercept on traditional metabolic risk factors for cardiovascular disease in patients with rheumatoid arthritis
por: Deodhar, Atul, et al.
Publicado: (2016) -
Treatment of Rheumatoid Arthritis with Biologic DMARDS (Rituximab and Etanercept)
por: Gashi, Afrim A., et al.
Publicado: (2014) -
Treatment Patterns and Costs in Biologic DMARD-Naive Patients with Rheumatoid Arthritis Initiating Etanercept or Adalimumab with or Without Methotrexate
por: Tkacz, Joseph, et al.
Publicado: (2020) -
Malignancies in children and young adults on etanercept: summary of cases from clinical trials and post marketing reports
por: Hooper, Michele, et al.
Publicado: (2013) -
Improved health outcomes with Etanercept versus usual DMARD therapy in an Asian population with established rheumatoid arthritis
por: Bae, Sang-Cheol, et al.
Publicado: (2013)